Fungal prion

Last updated
Formation of PSI+ prion causes S. cerevisiae cells with nonsense-mutation in ade1 gene to convert red pigment (colony below) into a colourless compound, causing colonies to become white (above) S.cerevisiae PSI+.jpg
Formation of PSI+ prion causes S. cerevisiae cells with nonsense-mutation in ade1 gene to convert red pigment (colony below) into a colourless compound, causing colonies to become white (above)

A fungal prion is a prion that infects hosts which are fungi. Fungal prions are naturally occurring proteins that can switch between multiple, structurally distinct conformations, at least one of which is self-propagating and transmissible to other prions. This transmission of protein state represents an epigenetic phenomenon where information is encoded in the protein structure itself, instead of in nucleic acids. Several prion-forming proteins have been identified in fungi, primarily in the yeast Saccharomyces cerevisiae . These fungal prions are generally considered benign, and in some cases even confer a selectable advantage to the organism. [1]

Contents

Fungal prions have provided a model for the understanding of disease-forming mammalian prions. Study of fungal prions has led to a characterisation of the sequence features and mechanisms that enable prion domains to switch between functional and amyloid-forming states.

Sequence features

Prions are formed by portable, transmissible prion domains that are often enriched in asparagine, glutamine, tyrosine and glycine residues. When a reporter protein is fused with a prion domain, it forms a chimeric protein that demonstrates the conformational switching that is characteristic of prions. Meanwhile, removing this prion domain prevents prionogenesis. This suggests that these prion domains are, in fact, portable and are the sole initiator of prionogenesis. This supports the protein-only hypothesis.[ citation needed ]

A recent study of candidate prion domains in S. cerevisiae found several specific sequence features that were common to proteins showing aggregation and self-templating properties. For example, proteins that aggregated had candidate prion domains that were more highly enriched in asparagine, while non-aggregating domains where more highly enriched in glutamine and charged peptides. There was also evidence that the spacing of charged peptides that prevent amyloid formation, such as proline, is important in prionogenesis. This discovery of sequence specificity was a departure from previous work that had suggested that the only determining factor in prionogenesis was the overall distribution of peptides. [2]

HET-s prion of Podospora anserina

Podospora anserina is a filamentous fungus. Genetically compatible colonies of this fungus can merge and share cellular contents such as nutrients and cytoplasm. A natural system of protective "incompatibility" proteins exists to prevent promiscuous sharing between unrelated colonies. One such protein, called HET-s, adopts a prion-like form in order to function properly. [3] [4] The prion form of HET-s spreads rapidly throughout the cellular network of a colony and can convert the non-prion form of the protein to a prion state after compatible colonies have merged. [5] However, when an incompatible colony tries to merge with a prion-containing colony, the prion causes the "invader" cells to die, ensuring that only related colonies obtain the benefit of sharing resources.

Prions of yeast

[PSI+] and [URE3]

In 1965, Brian Cox, a geneticist working with the yeast Saccharomyces cerevisiae , described a genetic trait (termed [PSI+]) with an unusual pattern of inheritance. The initial discovery of [PSI+] was made in a strain auxotrophic for adenine due to a nonsense mutation. [6] Despite many years of effort, Cox could not identify a conventional mutation that was responsible for the [PSI+] trait. In 1994, yeast geneticist Reed Wickner correctly hypothesized that [PSI+] as well as another mysterious heritable trait, [URE3], resulted from prion forms of the normal cellular proteins, Sup35p and Ure2p, respectively. [7] The names of yeast prions are frequently placed within brackets to indicate that they are non-mendelian in their passage to progeny cells, much like plasmid and mitochondrial DNA.[ citation needed ]

Further investigation found that [PSI+] is the result of a self-propagating misfolded form of Sup35p (a 201 amino acid long protein), which is an important factor for translation termination during protein synthesis. [8] In [PSI+] yeast cells the Sup35 protein forms filamentous aggregates known as amyloid. The amyloid conformation is self-propagating and represents the prion state. Amazingly distinct prion states exist for the Sup35 protein with distinct properties and these distinctions are self-propagating. [9] Other prions also can form distinct different variants (or strains). [10] It is believed that suppression of nonsense mutations in [PSI+] cells is due to a reduced amount of functional Sup35 because much of the protein is in the amyloid state. The Sup35 protein assembles into amyloid via an amino-terminal prion domain. The structure is based on the stacking of the prion domains in an in-register and parallel beta sheet conformation. [11]

An important finding by Chernoff, in a collaboration between the Liebman and Lindquist laboratories, was that a protein chaperone was required for [PSI+] to be maintained. [12] Because the only function of chaperones is to help proteins fold properly, this finding strongly supported Wickner's hypothesis that [PSI+] was a heritable protein state (i.e. a prion). Likewise, this finding also provided evidence for the general hypothesis that prions, including the originally proposed mammalian PrP prion, are heritable forms of protein. Because of the action of chaperones, especially Hsp104, proteins that code for [PSI+] and [URE3] can convert from non-prion to prion forms. For this reason, yeast prions are good models for studying factors like chaperones that affect protein aggregation. [10] Also, the IPOD is the sub-cellular site to which amyloidogenic proteins are sequestered in yeast, and where prions like [PSI+] may undergo maturation. [13] Thus, prions also serve as substrates to understand the intracellular processing of protein aggregates such as amyloid.[ citation needed ]

Laboratories commonly identify [PSI+] by growth of a strain auxotrophic for adenine on media lacking adenine, similar to that used by Cox et al. These strains cannot synthesize adenine due to a nonsense mutation in one of the enzymes involved in the biosynthetic pathway. When the strain is grown on yeast-extract/dextrose/peptone media (YPD), the blocked pathway results in buildup of a red-colored intermediate compound, which is exported from the cell due to its toxicity. Hence, color is an alternative method of identifying [PSI+] -- [PSI+] strains are white or pinkish in color, and [psi-] strains are red. A third method of identifying [PSI+] is by the presence of Sup35 in the pelleted fraction of cellular lysate.

When exposed to certain adverse conditions, in some genetic backgrounds [PSI+] cells actually fare better than their prion-free siblings; [14] this finding suggests that the ability to adopt a [PSI+] prion form may result from positive evolutionary selection. [15] It has been speculated that the ability to convert between prion-infected and prion-free forms acts as an evolutionary capacitor to enable yeast to quickly and reversibly adapt in variable environments. Nevertheless, Reed Wickner maintains that [URE3] and [PSI+] are diseases, [16] although this claim has been challenged using theoretical population genetic models. [17]

[PIN+] / [RNQ+]

The term [PIN+] was coined by Liebman and colleagues from Psi-INducibility, to describe a genetic requirement for the formation of the [PSI+] prion. [18] They showed that [PIN+] was required for the induction of most variants of the [PSI+] prion. Later they identified [PIN+] as the prion form of the RNQ1 protein [19] [20] [21] The more precise name [RNQ+] is now sometimes used because other factors or prions can also have a Psi-inducing phenotype.[ citation needed ]

A non-prion function of Rnq1 has not been definitively characterized. Though reasons for this are poorly understood, it is suggested that [PIN+] aggregates may act as "seeds" for the polymerization of [PSI+] and other prions. [22] [23] [24] The basis of the [PIN+] prion is an amyloid form of Rnq1 arranged in in-register parallel beta sheets, like the amyloid form of Sup35. [25] Due to similar amyloid structures, the [PIN+] prion may facilitate the formation of [PSI+] through a templating mechanism.[ citation needed ]

Two modified versions of Sup35 have been created that can induce PSI+ in the absence of [PIN+] when overexpressed. One version was created by digestion of the gene with the restriction enzyme Bal2, which results in a protein consisting of only the M and N portions of Sup35. [26] The other is a fusion of Sup35NM with HPR, a human membrane receptor protein.[ citation needed ]

Epigenetics

Prions act as an alternative form of non-Mendelian, phenotypic inheritance due to their self-templating ability. This makes prions a metastable, dominant mechanism for inheritance that relies solely on the conformation of the protein. Many proteins containing prion domains play a role in gene expression or RNA binding, which is how an alternative conformation can give rise to phenotypic variation. For example, the [psi-] state of Sup35 in yeast is a translation termination factor. When Sup35 undergoes a conformational change to the [PSI+] prion state, it forms amyloid fibrils and is sequestered, leading to more frequent stop codon read-through and the development of novel phenotypes. With over 20 prion-like domains identified in yeast, this gives rise to the opportunity for a significant amount of variation from a single proteome. It has been posited that this increased variation gives a selectable advantage to a population of genetically homogeneous yeast. [27]

List of characterized prions

Protein Natural HostNormal FunctionPrion StatePrion PhenotypeYear Identified
Ure2 Saccharomyces cerevisiae Nitrogen catabolite repressor[URE3]Growth on poor nitrogen sources1994
Sup35 Saccharomyces cerevisiae Translation termination factor[PSI+]Increased levels of nonsense suppression1994
HET-S Podospora anserina Regulates heterokaryon incompatibility[Het-s]Heterokaryon formation between incompatible strains1997
vacuolar protease B Saccharomyces cerevisiae death in stationary phase, failure in meiosis[β]failure to degrade cellular proteins under N starvation2003
MAP kinases Podospora anserina increased pigment, slow growth[C]2006
Rnq1p Saccharomyces cerevisiae Protein template factor[RNQ+],[PIN+]Promotes aggregation of other prions2000
Mca1* Saccharomyces cerevisiae Putative Yeast Caspase[MCA+]Unknown2008
Swi1 Saccharomyces cerevisiae Chromatin remodeling[SWI+]Poor growth on some carbon sources2008
Cyc8 Saccharomyces cerevisiae Transcriptional repressor[OCT+]Transcriptional derepression of multiple genes2009
Mot3 Saccharomyces cerevisiae Nuclear transcription factor[MOT3+]Transcriptional derepression of anaerobic genes2009
Pma1+Std1 [28] Saccharomyces cerevisiae Pma1 = major plasma membrane proton pump, Std1=minor pump[GAR+]Resistant to glucose-associated repression2009
Sfp1 [29] Saccharomyces cerevisiae Global transcriptional regulator[ISP+]Antisuppressor of certain sup35 mutations2010
Mod5 [30] Saccharomyces cerevisiae [MOD+]2012

[*The original paper that proposed Mca1 is a prion was retracted [31] ]

See also

Related Research Articles

<span class="mw-page-title-main">Prion</span> Pathogenic type of misfolded protein

A prion is a misfolded protein that can induce misfolding of normal variants of the same protein and trigger cellular death. Prions cause prion diseases known as transmissible spongiform encephalopathies (TSEs) that are fatal transmissible neurodegenerative diseases in humans and animals. The proteins may misfold sporadically, due to genetic mutations, or by exposure to an already misfolded protein. The consequent abnormal three-dimensional structure confers on them the ability to cause misfolding of other proteins.

<span class="mw-page-title-main">Susan Lindquist</span> American geneticist

Susan Lee Lindquist, ForMemRS was an American professor of biology at MIT specializing in molecular biology, particularly the protein folding problem within a family of molecules known as heat-shock proteins, and prions. Lindquist was a member and former director of the Whitehead Institute and was awarded the National Medal of Science in 2010.

<span class="mw-page-title-main">Structural inheritance</span>

Structural inheritance or cortical inheritance is the transmission of an epigenetic trait in a living organism by a self-perpetuating spatial structures. This is in contrast to the transmission of digital information such as is found in DNA sequences, which accounts for the vast majority of known genetic variation.

Sup35p is the Saccharomyces cerevisiae eukaryotic translation release factor. More specifically, it is the yeast eukaryotic release factor 3 (eRF3), which forms the translation termination complex with eRF1. This complex recognizes and catalyzes the release of the nascent polypeptide chain when the ribosome encounters a stop codon. While eRF1 recognizes stop codons, eRF3 facilitates the release of the polypeptide chain through GTP hydrolysis.

Evolutionary capacitance is the storage and release of variation, just as electric capacitors store and release charge. Living systems are robust to mutations. This means that living systems accumulate genetic variation without the variation having a phenotypic effect. But when the system is disturbed, robustness breaks down, and the variation has phenotypic effects and is subject to the full force of natural selection. An evolutionary capacitor is a molecular switch mechanism that can "toggle" genetic variation between hidden and revealed states. If some subset of newly revealed variation is adaptive, it becomes fixed by genetic assimilation. After that, the rest of variation, most of which is presumably deleterious, can be switched off, leaving the population with a newly evolved advantageous trait, but no long-term handicap. For evolutionary capacitance to increase evolvability in this way, the switching rate should not be faster than the timescale of genetic assimilation.

Reed B. Wickner is an American yeast geneticist. In 1994 he proposed that the [PSI+] and [URE3] phenotypes in Saccharomyces cerevisiae, a form of budding yeast, were caused by prion forms of native proteins - specifically, the Sup35p and Ure2p proteins, respectively.

The Ty5 is a type of retrotransposon native to the Saccharomyces cerevisiae organism.

<span class="mw-page-title-main">CRAL-TRIO domain</span>

CRAL-TRIO domain is a protein structural domain that binds small lipophilic molecules. This domain is named after cellular retinaldehyde-binding protein (CRALBP) and TRIO guanine exchange factor.

<span class="mw-page-title-main">CDC20</span> Protein-coding gene in the species Homo sapiens

The cell division cycle protein 20 homolog is an essential regulator of cell division that is encoded by the CDC20 gene in humans. To the best of current knowledge its most important function is to activate the anaphase promoting complex (APC/C), a large 11-13 subunit complex that initiates chromatid separation and entrance into anaphase. The APC/CCdc20 protein complex has two main downstream targets. Firstly, it targets securin for destruction, enabling the eventual destruction of cohesin and thus sister chromatid separation. It also targets S and M-phase (S/M) cyclins for destruction, which inactivates S/M cyclin-dependent kinases (Cdks) and allows the cell to exit from mitosis. A closely related protein, Cdc20homologue-1 (Cdh1) plays a complementary role in the cell cycle.

<span class="mw-page-title-main">Cell division cycle 7-related protein kinase</span> Protein-coding gene in the species Homo sapiens

Cell division cycle 7-related protein kinase is an enzyme that in humans is encoded by the CDC7 gene. The Cdc7 kinase is involved in regulation of the cell cycle at the point of chromosomal DNA replication. The gene CDC7 appears to be conserved throughout eukaryotic evolution; this means that most eukaryotic cells have the Cdc7 kinase protein.

<span class="mw-page-title-main">UBE2G2</span> Protein-coding gene in the species Homo sapiens

Ubiquitin-conjugating enzyme E2 G2 is a protein that in humans is encoded by the UBE2G2 gene.

<span class="mw-page-title-main">CDC40</span> Protein-coding gene in the species Homo sapiens

Pre-mRNA-processing factor 17 is a protein that in humans is encoded by the CDC40 gene.

<span class="mw-page-title-main">EXOC7</span> Protein-coding gene in the species Homo sapiens

Exocyst complex component 7 is a protein that in humans is encoded by the EXOC7 gene. It was formerly known as Exo70.

<span class="mw-page-title-main">DNAJA2</span> Protein-coding gene in the species Homo sapiens

DnaJ homolog subfamily A member 2 is a protein that in humans is encoded by the DNAJA2 gene.

<span class="mw-page-title-main">Centrin 3</span> Protein-coding gene in the species Homo sapiens

Centrin-3 is a protein that in humans is encoded by the CETN3 gene. It belongs to the centrin family of proteins.

<span class="mw-page-title-main">MED31</span> Protein-coding gene in the species Homo sapiens

Mediator of RNA polymerase II transcription subunit 31 is a protein in humans encoded by the MED31 gene. It represents subunit Med31 of the Mediator complex. The family contains the Saccharomyces cerevisiae SOH1 homologues. SOH1 is responsible for the repression of temperature sensitive growth of the HPR1 mutant and has been found to be a component of the RNA polymerase II transcription complex. SOH1 not only interacts with factors involved in DNA repair, but transcription as well. Thus, the SOH1 protein may serve to couple these two processes.

<span class="mw-page-title-main">APBB2</span> Protein-coding gene in the species Homo sapiens

Amyloid beta A4 precursor protein-binding family B member 2 is a protein that in humans is encoded by the APBB2 gene.

<span class="mw-page-title-main">SDD-AGE</span> Method for detecting large protein polymers

In biochemistry and molecular biology, SDD-AGE is short for Semi-Denaturating Detergent Agarose Gel Electrophoresis. This is a method for detecting and characterizing large protein polymers which are stable in 2% SDS at room temperature, unlike most large protein complexes. This method is very useful for studying prions and amyloids, which are characterized by the formation of proteinaceous polymers. Agarose is used for the gel since the SDS-resistant polymers are large and cannot enter a conventional polyacrylamide gel, which has small pores. Agarose on the other hand has large pores, which allows for the separation of polymers.

Ure2, or Ure2p, is a yeast protein encoded by a gene known as URE2. The Ure2 protein can also form a yeast prion known as [URE3]. When Ura2p is expressed at high levels in yeast, it will readily convert from its native protein conformation into an aggregate known as an amyloid. [URE3], along with [PSI+], were both determined by Wickner (1994) to meet the genetic definition of a yeast prion.

Hsp104 is a heat-shock protein. It is known to reverse toxicity of mutant α-synuclein, TDP-43, FUS, and TAF15 in yeast cells. Conserved in prokaryotes (ClpB), fungi, plants and as well as animal mitochondria, there is yet to see hsp104 in multicellular animals. Hsp104 is classified as a. AAA+ ATPases and a subgroup of Hsp100/Clp, because of the usage of Atp hydrolysis for structural modulation of other proteins. Hsp104 is not needed for normal cell growth but when exposed to stress there is an increase amount. Removing the aggregates without the hsp104 is insufficient there highlighting the importance of this heat shock protein and its interactions.

References

  1. ↑ Michelitsch MD, Weissman JS (2000). "A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions". Proc Natl Acad Sci U S A. 97 (22): 11910–5. Bibcode:2000PNAS...9711910M. doi: 10.1073/pnas.97.22.11910 . JSTOR   123764. PMC   17268 . PMID   11050225.
  2. ↑ Alberti S, Halfmann R, King O, Kapila A, Lindquist S (2009). "A Systematic Survey Identifies Prions and Illuminates Sequence Features of Prionogenic Proteins". Cell. 137 (1): 146–158. doi:10.1016/j.cell.2009.02.044. PMC   2683788 . PMID   19345193.
  3. ↑ Coustou V, Deleu C, Saupe S, Begueret J (1997). "The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog". Proc Natl Acad Sci U S A. 94 (18): 9773–8. Bibcode:1997PNAS...94.9773C. doi: 10.1073/pnas.94.18.9773 . JSTOR   43101. PMC   23266 . PMID   9275200.
  4. ↑ Greenwald J, Buhtz C, Ritter C, Kwiatkowski W, Choe S, Maddelein ML, Ness F, Cescau S, Soragni A, Leitz D, Saupe SJ, Riek R (2010). "The mechanism of prion inhibition by HET-S". Molecular Cell. 38 (6): 889–99. doi:10.1016/j.molcel.2010.05.019. PMC   3507513 . PMID   20620958.
  5. ↑ Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ (2002). "Amyloid aggregates of the HET-s prion protein are infectious". Proc Natl Acad Sci U S A. 99 (11): 7402–7. Bibcode:2002PNAS...99.7402M. doi: 10.1073/pnas.072199199 . JSTOR   3058837. PMC   124243 . PMID   12032295.
  6. ↑ Cox BS, Tuite MF, McLaughlin CS (1988). "The psi factor of yeast: a problem in inheritance". Yeast. 4 (3): 159–78. doi:10.1002/yea.320040302. PMID   3059716. S2CID   84886030.
  7. ↑ Wickner RB (1994). "[URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae". Science. 264 (5158): 566–9. Bibcode:1994Sci...264..566W. doi:10.1126/science.7909170. PMID   7909170.
  8. ↑ Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD (1996). "Propagation of the yeast prion-like PSI+ determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor". EMBO Journal. 15 (12): 3127–34. doi:10.1002/j.1460-2075.1996.tb00675.x. PMC   450255 . PMID   8670813.
  9. ↑ Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG, Liebman SW (1996). "Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae". Genetics. 144 (4): 1375–86. doi:10.1093/genetics/144.4.1375. PMC   1207691 . PMID   8978027.
  10. 1 2 Liebman SW, Chernoff YO (2012). "Prions in yeast". Genetics. 191 (4): 1041–72. doi:10.1534/genetics.111.137760. PMC   3415993 . PMID   22879407.
  11. ↑ Shewmaker F, Wickner RB, Tycko R (December 2006). "Amyloid of the prion domain of Sup35p has an in-register parallel β-sheet structure". Proc Natl Acad Sci U S A. 103 (52): 19754–9. Bibcode:2006PNAS..10319754S. doi: 10.1073/pnas.0609638103 . JSTOR   30051383. PMC   1750918 . PMID   17170131.
  12. ↑ Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW (1995). "Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]". Science. 268 (5212): 880–4. Bibcode:1995Sci...268..880C. doi:10.1126/science.7754373. PMID   7754373.
  13. ↑ Tyedmers J, Treusch S, Dong J, McCaffery JM, Bevis B, Lindquist S (May 2010). "Prion induction involves an ancient system for the sequestration of aggregated proteins and heritable changes in prion fragmentation". Proc Natl Acad Sci U S A. 107 (19): 8633–8. Bibcode:2010PNAS..107.8633T. doi: 10.1073/pnas.1003895107 . JSTOR   25681468. PMC   2889312 . PMID   20421488.
  14. ↑ True HL, Lindquist SL (2000). "A yeast prion provides a mechanism for genetic variation and phenotypic diversity". Nature. 407 (6803): 477–83. Bibcode:2000Natur.407..477T. doi:10.1038/35035005. PMID   11028992. S2CID   4411231.
  15. ↑ Lancaster AK, Bardill JP, True HL, Masel J (2010). "The Spontaneous Appearance Rate of the Yeast Prion [PSI+] and Its Implications for the Evolution of the Evolvability Properties of the [PSI+] System". Genetics. 184 (2): 393–400. doi:10.1534/genetics.109.110213. PMC   2828720 . PMID   19917766.
  16. ↑ Nakayashiki T, Kurtzman CP, Edskes HK, Wickner RB (2005). "Yeast prions [URE3] and [PSI+] are diseases". Proc Natl Acad Sci U S A. 102 (30): 10575–80. Bibcode:2005PNAS..10210575N. doi: 10.1073/pnas.0504882102 . JSTOR   3376125. PMC   1180808 . PMID   16024723.
  17. ↑ Griswold CK, Masel J (2009). "The Strength of Selection Against the Yeast Prion [PSI+]". Genetics. 181 (3): 1057–1063. doi:10.1534/genetics.108.100297. PMC   2651042 . PMID   19153253.
  18. ↑ Derkatch IL, Bradley ME, Zhou P, Chernoff YO, Liebman SW (1997). "Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae". Genetics. 147 (2): 507–19. doi:10.1093/genetics/147.2.507. PMC   1208174 . PMID   9335589.
  19. ↑ Derkatch IL, Bradley ME, Hong JY, Liebman SW (2001). "Prions affect the appearance of other prions: the story of [PIN(+)]". Cell. 106 (2): 171–82. doi: 10.1016/s0092-8674(01)00427-5 . PMID   11511345. S2CID   18501467.
  20. ↑ Sondheimer N, Lindquist S (2000). "Rnq1: an epigenetic modifier of protein function in yeast". Mol Cell. 5 (1): 163–72. doi: 10.1016/s1097-2765(00)80412-8 . PMID   10678178.
  21. ↑ Patel BK, Liebman SW (2007). ""Prion-proof" for [PIN+]: infection with in vitro-made amyloid aggregates of Rnq1p-(132-405) induces [PIN+]". J Mol Biol. 365 (3): 773–82. doi:10.1016/j.jmb.2006.10.069. PMC   2570204 . PMID   17097676.
  22. ↑ Derkatch IL, Liebman SW (2007). "Prion-prion interactions". Prion. 1 (3): 161–9. doi:10.4161/pri.1.3.4837. PMC   2634589 . PMID   19164893.
  23. ↑ Serio TR (2018). "[PIN+]ing down the mechanism of prion appearance". FEMS Yeast Res. 18 (3). doi:10.1093/femsyr/foy026. PMC   5889010 . PMID   29718197.
  24. ↑ Chernoff YO (2001). "Mutation processes at the protein level: Is Lamarck back?". Mutation Research. 488 (1): 39–64. Bibcode:2001MRRMR.488...39C. doi:10.1016/S1383-5742(00)00060-0. PMID   11223404.
  25. ↑ Wickner RB, Dyda F, Tycko R (February 2008). "Amyloid of Rnq1p, the basis of the PIN+ prion, has a parallel in-register beta-sheet structure". Proc Natl Acad Sci U S A. 105 (7): 2403–8. Bibcode:2008PNAS..105.2403W. doi: 10.1073/pnas.0712032105 . JSTOR   25451479. PMC   2268149 . PMID   18268327.
  26. ↑ Derkatch IL, Bradley ME, Zhou P, Chernoff YO, Liebman SW (1997). "Genetic and Environmental Factors Affecting the de novo Appearance of the [PSI+] Prion in Saccharomyces cerevisiae". Genetics. 147 (2): 507–519. doi:10.1093/genetics/147.2.507. PMC   1208174 . PMID   9335589.
  27. ↑ Halfmann R, Jarosz DF, Jones SK, Chang A, Lancaster AK, Lindquist S (2012). "Prions are a common mechanism for phenotypic inheritance in wild yeasts". Nature. 482 (7385): 363–U1507. Bibcode:2012Natur.482..363H. doi:10.1038/nature10875. PMC   3319070 . PMID   22337056.
  28. ↑ Brown JC, Lindquist S (2009). "A heritable switch in carbon source utilization driven by an unusual yeast prion". Genes Dev. 23 (19): 2320–32. doi:10.1101/gad.1839109. PMC   2758746 . PMID   19797769.
  29. ↑ Rogoza T, Goginashvili A, Rodionova S, Ivanov M, Viktorovskaya O, Rubel A, Volkov K, Mironova L (2010). "Non-Mendelian determinant [ISP+] in yeast is a nuclear-residing prion form of the global transcriptional regulator Sfp1". Proc Natl Acad Sci U S A. 107 (23): 10573–7. Bibcode:2010PNAS..10710573R. doi: 10.1073/pnas.1005949107 . JSTOR   25681824. PMC   2890785 . PMID   20498075.
  30. ↑ Suzuki G, Shimazu N, Tanaka M (2012). "A Yeast Prion, Mod5, Promotes Acquired Drug Resistance and Cell Survival Under Environmental Stress". Science. 336 (6079): 355–359. Bibcode:2012Sci...336..355S. doi:10.1126/science.1219491. PMID   22517861. S2CID   206540234.
  31. ↑ Nemecek J, Nakayashiki T, Wickner RB (2011). "Retraction for Nemecek et al., A prion of yeast metacaspase homolog (Mca1p) detected by a genetic screen". Proc Natl Acad Sci U S A. 108 (24): 10022. Bibcode:2011PNAS..108R0022.. doi: 10.1073/pnas.1107490108 . PMC   3116407 . PMID   21628591.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.